James Young
Chairman en NOVAVAX, INC. .
Fortuna: 335 030 $ al 31/03/2024
Origen de la red de primer grado James Young.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
73
| Subsidiary | Biotechnology | 73 |
| Public Company | Biotechnology | 56 | |
| Public Company | Pharmaceuticals: Major | 19 | |
Icahn School of Medicine at Mount Sinai
10
| College/University | Other Consumer Services | 10 |
| Subsidiary | Biotechnology | 5 | |
| Subsidiary | Agricultural Commodities/Milling | 4 | |
| Public Company | Biotechnology | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a James Young a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| AETNA | Managed Health Care | Corporate Officer/Principal Corporate Officer/Principal | |
| GENVEC INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman President Chairman | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| MAXCYTE, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | President Founder President Private Equity Investor | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
| ASTRIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Chairman Founder | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Operating Officer | |
| TESARO INC | Pharmaceuticals: Major | Founder Chairman Director of Finance/CFO | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Virginia | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Dartmouth College | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| American University | College/University | Undergraduate Degree Graduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree Director/Board Member Graduate Degree Undergraduate Degree | |
| Santa Clara University | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Founder Chairman | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Investor Relations Contact | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer | |
| SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Chief Administrative Officer Chief Operating Officer | |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Corporate Officer/Principal Founder Corporate Officer/Principal | |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chairman |
Estadísticas
Internacional
| Estados Unidos | 49 |
| Reino Unido | 3 |
Sectorial
| Health Technology | 30 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Health Services | 2 |
| Finance | 2 |
Operativa
| Director/Board Member | 315 |
| Corporate Officer/Principal | 239 |
| Independent Dir/Board Member | 93 |
| Chief Executive Officer | 87 |
| Undergraduate Degree | 84 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| David Mott | 45 |
| Peter Greenleaf | 31 |
| Gail Boudreaux | 30 |
| Peter Kiener | 25 |
| Gary Evans | 25 |
| Wayne T. Hockmeyer | 22 |
| Rahul Singhvi | 22 |
| Gregg Alton | 22 |
| Fred Driscoll | 21 |
| Jinzi Wu | 20 |
| Gordon Ringold | 20 |
| Hal R. Werner | 17 |
| Rekha Hemrajani | 17 |
| Barclay Phillips | 16 |
| Bahija Jallal | 16 |
- Bolsa de valores
- Insiders
- James Young
- Conexiones Empresas
